期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 55, 期 11, 页码 5168-5171出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.05273-11
关键词
-
资金
- U.S. Centers for Disease Control and Prevention (CDC)
Antiretroviral drugs cross from maternal plasma to breast milk and from breast milk to the infant in different concentrations. We measured concentrations of nelfinavir and its active metabolite (M8) in maternal plasma and breast milk from women and in dried blood spots collected from their infants at delivery and postnatal weeks 2, 6, 14, and 24 in the Kisumu Breastfeeding Study, Kisumu, Kenya. Nelfinavir-based antiretroviral regimens given to mothers as prevention of mother-to-child HIV transmission (PMTCT) do not expose the breast-feeding infant to biologically significant concentrations of nelfinavir or M8.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据